TGM RESEARCH BLOG
Healthcare and Pharmaceutical Research Use Cases: To Choose the Right Study
Which healthcare research use case matches the decision in front of your team?
A pharmaceutical launch, clinical trial, digital health rollout, or market entry plan each requires a different audience and evidence framework. Selecting the wrong research focus can produce broad findings that fail to guide product positioning, patient support, professional adoption, or access planning.
This guide explains 13 healthcare and pharmaceutical market research use cases, what each study needs to validate, and the next decision the evidence supports.
A pharmaceutical launch, clinical trial, digital health rollout, or market entry plan each requires a different audience and evidence framework. Selecting the wrong research focus can produce broad findings that fail to guide product positioning, patient support, professional adoption, or access planning.
This guide explains 13 healthcare and pharmaceutical market research use cases, what each study needs to validate, and the next decision the evidence supports.
Key Highlights
Understand how to apply each healthcare and pharmaceutical research use case to support your strategic decisions and evidence needs:- Pharmaceutical benchmarking
- Clinical trial recruitment research
- Access to rare and hard-to-reach patient groups
- Physician and HCP insight
- Payer, reimbursement, and market access research
- Treatment pathway and care gap research
- Digital health, telehealth, and AI adoption research
- Healthcare message and medical claims testing
- Patient segmentation by condition, behavior, and care needs
- OTC, pharmacy, and consumer health research
- Medical device and diagnostics usability research
- Healthcare market entry and local validation
- Quick-turn healthcare research
1. Pharmaceutical Benchmarking
Applying pharmaceutical benchmarking to reduce commercial uncertainty before launching or repositioning.
By comparing physician preference, pharmacist recommendation behavior, patient perception, pricing acceptance, and message strength against existing alternatives, you can identify whether the product has a clear market advantage or needs stronger positioning.
By comparing physician preference, pharmacist recommendation behavior, patient perception, pricing acceptance, and message strength against existing alternatives, you can identify whether the product has a clear market advantage or needs stronger positioning.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Physician or pharmacist perception | Whether HCPs see the product as clinically relevant, easy to recommend, and different from alternatives. | Refine product positioning, strengthen professional messaging, or adjust education materials for HCP engagement. |
| Patient perception | If patients understand the benefit, trust the claim, and see the product as suitable for their condition or routine. | Improve patient-facing claims, packaging language, campaign messages, or product education content. |
| Pricing acceptance | How the target audience evaluates the product price compared with branded and generic alternatives. | Review pricing, bundle strategy, discount logic, or value communication before launch. |
| Competitive comparison | Which brands, generics, or substitute products are seen as stronger, cheaper, safer, or more familiar. | Adjust market positioning, identify differentiation gaps, or prioritize competitor-specific messaging. |
2. Clinical Trial Recruitment Research
Clinical trial recruitment research helps sponsors assess whether the right patients are reachable within a realistic timeline.
Recruitment delays create pressure on trial budgets, product development plans, and launch timelines. Research helps evaluate patient availability, trial awareness, eligibility barriers, willingness to participate, travel burden, trust concerns, and retention risks before recruitment begins.
Recruitment delays create pressure on trial budgets, product development plans, and launch timelines. Research helps evaluate patient availability, trial awareness, eligibility barriers, willingness to participate, travel burden, trust concerns, and retention risks before recruitment begins.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Patient availability | The size and reachability of the target patient group in selected markets or geographies. | Adjust market selection, recruitment targets, site planning, or patient access strategy. |
| Eligibility barriers | How diagnosis stage, treatment history, comorbidities, or exclusion criteria affect recruitment feasibility. | Review feasibility assumptions, refine screening logic, or reassess recruitment expectations. |
| Participation willingness | The level of patient openness to joining the trial and the concerns that reduce interest. | Improve patient communication, consent explanation, trial education, or recruitment materials. |
| Retention risk | Whether travel burden, visit frequency, fear of side effects, time pressure, or family responsibility affects continued participation. | Improve retention planning, patient support, visit scheduling, or follow-up communication. |
3. Access To Rare And Hard-To-Reach Patient Groups
Rare and hard-to-reach patient research allows you to understand patient groups that standard consumer sampling cannot reach.
These groups include rare disease patients, patients at a specific diagnosis stage, treatment-experienced patients, relapsed patients, patients using specialty therapies, caregivers of people with chronic conditions, or patients living in areas with limited access to specialist care.
These groups include rare disease patients, patients at a specific diagnosis stage, treatment-experienced patients, relapsed patients, patients using specialty therapies, caregivers of people with chronic conditions, or patients living in areas with limited access to specialist care.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Patient identification | Whether the target patient group can be reached based on condition, diagnosis stage, treatment history, or care pathway. | Refine screening criteria, adjust recruitment sources, or define a more realistic respondent profile. |
| Diagnosis journey | Where patients experience delays, misdiagnosis, referral gaps, or lack of specialist access. | Improve patient education, referral support, HCP communication, or awareness materials. |
| Treatment behavior | How patients start, stop, switch, or continue treatment in real life. | Strengthen treatment support, improve adherence programs, or refine patient communication. |
| Emotional and daily burden | What patients and caregivers struggle with beyond clinical symptoms, such as fatigue, stigma, cost, family pressure, or daily care routines. | Design more patient-centered support tools, caregiver resources, and communication content. |
| Support needs | What patients expect from pharmaceutical companies, healthcare providers, advocacy groups, or digital support programs. | Build patient support programs, educational materials, reminder systems, or community engagement strategies. |
4. Physician And HCP Insight
Physician and HCP insight research reveals how medical professionals make decisions in real clinical settings.
Healthcare adoption depends on more than product benefits. Physicians, pharmacists, nurses, specialists, and healthcare administrators each shape how treatments, devices, diagnostics, and support programs move through the care pathway.
Their decisions are influenced by clinical confidence, workflow pressure, patient suitability, evidence quality, and institutional constraints.
Healthcare adoption depends on more than product benefits. Physicians, pharmacists, nurses, specialists, and healthcare administrators each shape how treatments, devices, diagnostics, and support programs move through the care pathway.
Their decisions are influenced by clinical confidence, workflow pressure, patient suitability, evidence quality, and institutional constraints.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Prescribing behavior | How physicians choose treatments, compare options, and decide when to switch patients. | Refine treatment positioning, clinical messaging, or launch education materials. |
| Treatment pathway understanding | How patients move through diagnosis, referral, treatment initiation, follow-up, and long-term management. | Identify pathway gaps, improve HCP education, or support earlier intervention strategies. |
| Unmet clinical needs | Which problems HCPs still face with existing treatments, devices, diagnostics, or support tools. | Prioritize product benefits, evidence generation, or service improvements. |
| Workflow friction | Whether a product, tool, or program fits real clinical routines or adds extra workload. | Improve product design, onboarding, training, or implementation support. |
| Medical message response | Whether HCPs find the claims credible, relevant, clear, and supported by evidence. | Refine HCP-facing messages, sales materials, medical education content, or KOL discussion points. |
| Adoption barriers | What prevents HCPs from recommending, prescribing, using, or supporting a healthcare solution. | Address evidence gaps, adjust market access strategy, strengthen professional communication, or modify launch planning. |
5. Payer, Reimbursement, And Market Access Research
Market access research supports to find out what evidence is required for pricing, reimbursement, formulary acceptance, and broader market access.
A clinically strong product still faces commercial barriers when payers question cost, budget impact, comparative value, or long-term outcomes. Studies with payers, providers, and healthcare decision-makers will identify affordability concerns, evidence expectations, access barriers, and value communication gaps before launching.
A clinically strong product still faces commercial barriers when payers question cost, budget impact, comparative value, or long-term outcomes. Studies with payers, providers, and healthcare decision-makers will identify affordability concerns, evidence expectations, access barriers, and value communication gaps before launching.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Evidence expectations | What clinical and economic evidence payers need before supporting reimbursement or formulary inclusion. | Strengthen HEOR (Health Economics and Outcomes Research) planning. |
| Budget impact | Whether the product price creates concern around affordability, patient volume, treatment duration, or total cost to the healthcare system. | Refine pricing logic, access assumptions, patient segmentation, or budget impact communication. |
| Comparative value | How payers compare the product against existing therapies, generics, devices, or standard care options. | Improve value proposition, competitor framing, and payer-facing message hierarchy. |
| Access barriers | What prevents reimbursement, formulary acceptance, provider adoption, or patient access in the target market. | Adjust market access strategy, reimbursement pathway, stakeholder engagement, or launch sequencing. |
6. Treatment Pathway And Care Gap Research
Treatment pathway and care gap research maps how patients progress through diagnosis, treatment selection, follow-up, and long-term care.
In many therapeutic areas, the biggest commercial barrier is not demand alone. Patients face late diagnosis, referral delays, fragmented care, poor follow-up, unclear treatment choices, and low confidence in available options. Research then identify where the care pathway breaks and which stakeholders influence each decision point
In many therapeutic areas, the biggest commercial barrier is not demand alone. Patients face late diagnosis, referral delays, fragmented care, poor follow-up, unclear treatment choices, and low confidence in available options. Research then identify where the care pathway breaks and which stakeholders influence each decision point
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Diagnosis pathway | Where patients experience delays, misdiagnosis, low awareness, or difficulty reaching the right specialist. | Improve disease education, referral support, screening communication, or HCP awareness activities. |
| Treatment selection | How patients and HCPs choose between treatment options and what factors influence switching or discontinuation. | Refine treatment positioning, patient education, HCP messaging, or support materials. |
| Care gaps | Where patients lose support during follow-up, long-term treatment, monitoring, or lifestyle management. | Build patient support programs, adherence tools, follow-up reminders, or care coordination resources. |
| Stakeholder influence | Which stakeholders shape each stage of the pathway, such as GPs, specialists, pharmacists, caregivers, payers, or hospitals. | Prioritize stakeholder engagement, communication channels, and education strategy. |
| Access barriers | What prevents patients from receiving the right care, including cost, geography, appointment delays, insurance limits, or low trust. | Adjust access strategy, market segmentation, affordability support, or local market planning. |
7. Digital Health And AI Adoption Research
Digital health and AI adoption research assesses how patients and healthcare professionals trust and engage with digital healthcare tools in real care settings.
Telehealth platforms, remote monitoring systems, AI triage tools, patient portals, mobile health apps, and clinical workflow software depend on more than technical performance.
Telehealth platforms, remote monitoring systems, AI triage tools, patient portals, mobile health apps, and clinical workflow software depend on more than technical performance.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Patient trust | How patients judge the tool’s safety, privacy, and relevance to their health concerns. | Improve privacy messaging, human oversight explanation, onboarding content, and patient-facing education. |
| HCP workflow fit | Whether doctors, nurses, pharmacists, or administrators can use the tool without extra burden. | Refine product design, reduce workflow friction, improve integration, or adjust implementation support. |
| Usability and onboarding | How clearly users know how to start, navigate, interpret results, and complete key actions. | Improve UX design, onboarding steps, help content, and user guidance. |
| Feature relevance | Which features patients or HCPs actually value, ignore, misunderstand, or find unnecessary. | Prioritize product roadmap, simplify features, or reposition the tool around stronger use cases. |
| Privacy and data concerns | What concerns stop users from feeling comfortable sharing symptoms, medical records, monitoring data, or personal health information. | Strengthen consent flows, data protection explanation, trust messaging, and transparency. |
| Reasons for abandonment | Why users stop using the platform, skip follow-ups, ignore alerts, or return to offline care. | Improve engagement design, reminder logic, clinical escalation pathways, and retention strategy. |
8. Healthcare Message And Medical Claims Testing
Healthcare message and medical claims testing assesses whether product claims are clear, credible, and correctly interpreted by patients, physicians, pharmacists, and payers.
Medical claims require careful wording because unclear language creates confusion or compliance risk. A benefit statement that sounds persuasive to an internal team may feel too vague to physicians, too technical for patients, too unsupported for payers, or too sensitive for compliance review.
For example, a pharmaceutical company preparing patient education materials for a new chronic disease treatment may use the claim “improved symptom control.” Without testing, different audiences may interpret the message in different ways. Patients may expect complete symptom relief, physicians may look for measurable clinical improvement, and payers may ask whether the outcome reduces long-term healthcare costs. Message testing identifies these interpretation gaps and refines the wording so the claim feels clear, credible, and appropriate for each audience.
Medical claims require careful wording because unclear language creates confusion or compliance risk. A benefit statement that sounds persuasive to an internal team may feel too vague to physicians, too technical for patients, too unsupported for payers, or too sensitive for compliance review.
For example, a pharmaceutical company preparing patient education materials for a new chronic disease treatment may use the claim “improved symptom control.” Without testing, different audiences may interpret the message in different ways. Patients may expect complete symptom relief, physicians may look for measurable clinical improvement, and payers may ask whether the outcome reduces long-term healthcare costs. Message testing identifies these interpretation gaps and refines the wording so the claim feels clear, credible, and appropriate for each audience.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Benefit statement clarity | How accurately patients, HCPs, pharmacists, or payers understand the intended product benefit. | Refine claim wording, simplify patient language, or strengthen HCP-facing explanation. |
| Risk and safety communication | How clearly the audience understand side effects, warnings, usage limits, and safety information. | Improve risk explanation, patient information materials, or HCP counselling support. |
| Evidence credibility | Whether the audience sees the claim as supported by enough clinical or comparative evidence. | Add stronger evidence framing, improve data presentation, or adjust the message hierarchy. |
| Audience-specific interpretation | Whether different stakeholders understand the same message differently. | Create separate message versions for patients, HCPs, pharmacists, payers, or caregivers. |
| Compliance sensitivity | Which wording creates confusion, overpromise, promotional risk, or unsupported interpretation. | Review claim language, align with medical and compliance teams, or adjust launch communication. |
| Call-to-action response | How the message influences intended actions, such as asking a doctor, discussing treatment, requesting information, or considering a product. | Refine patient education flow, HCP discussion guide, campaign content, or pharmacy communication. |
9. Patient Segmentation By Condition, Behavior, And Care Needs
Patient segmentation by condition, behavior, and care needs helps you group patients by the factors that truly shape treatment decisions and support needs.
Basic demographics rarely explain healthcare behavior well enough. Patients with the same age or income profile may differ significantly by diagnosis stage, treatment experience, symptom burden, adherence behavior, caregiver support, care access, digital readiness, trust in providers, or affordability pressure. Also, segmentation can help you determine which patients need education, which need practical support, which need reassurance, and which need a different access model.
Basic demographics rarely explain healthcare behavior well enough. Patients with the same age or income profile may differ significantly by diagnosis stage, treatment experience, symptom burden, adherence behavior, caregiver support, care access, digital readiness, trust in providers, or affordability pressure. Also, segmentation can help you determine which patients need education, which need practical support, which need reassurance, and which need a different access model.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Condition stage | How patients at different diagnosis or disease progression stages experience fears and decision barriers. | Build stage-specific education, treatment support, or engagement plans. |
| Treatment experience | How patients behave when they are using, switching, stopping, or avoiding treatment. | Create separate messaging for treatment-naive, experienced, switcher, or discontinuing patients. |
| Adherence behavior | Which patients follow treatment, skip doses, delay refills, stop therapy, or use treatment inconsistently. | Design adherence programs, reminder systems, refill support, or HCP discussion tools. |
| Care access barriers | How cost, geography, insurance, appointment availability, pharmacy access, or specialist access shapes patient behavior. | Adjust access strategy, affordability support, channel planning, or local market prioritization. |
| Trust and information needs | How patients rely on doctors, pharmacists, online sources, peer communities, or brand information when making healthcare decisions. | Select the right communication channels, evidence formats, and education materials. |
| Caregiver involvement | How family members or caregivers influence treatment routines, doctor visits, purchase decisions, or emotional support. | Develop caregiver resources, shared decision tools, or family-focused patient support. |
| Digital readiness | How comfortable patients feel using telehealth, apps, remote monitoring, portals, or digital reminders. | Personalize digital support, offer offline alternatives, or improve onboarding for lower-readiness groups. |
| Affordability pressure | How price, reimbursement, refill cost, or long-term therapy expense affects treatment continuation. | Refine pricing communication, access support, patient assistance, or value messaging. |
10. OTC, Pharmacy, And Consumer Health Research
OTC, pharmacy, and consumer health research evaluates the factors shaping consumer choice, pharmacist recommendations, and purchase behavior in non-prescription healthcare categories.
For OTC medicines, supplements, personal health products, and wellness solutions, the pharmacy often becomes a key decision point. Consumers may enter the category with a symptom, a health concern, a brand they remember, or a recommendation from family, online content, or a pharmacist.
Research helps you find out category triggers, pharmacist recommendations, shelf competition, claim understanding, price sensitivity, and repeat purchase drivers.
For OTC medicines, supplements, personal health products, and wellness solutions, the pharmacy often becomes a key decision point. Consumers may enter the category with a symptom, a health concern, a brand they remember, or a recommendation from family, online content, or a pharmacist.
Research helps you find out category triggers, pharmacist recommendations, shelf competition, claim understanding, price sensitivity, and repeat purchase drivers.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Category triggers | What symptoms, health concerns, routines, or life situations lead consumers to seek an OTC product, supplement, or wellness solution. | Refine target audience, usage occasions, campaign angle, and product education content. |
| Pharmacist recommendation behavior | How pharmacists assess consumer needs, compare brands, and recommend OTC products or supplements. | Build pharmacist education, improve product detail materials, and strengthen pharmacy engagement. |
| Shelf and brand competition | Which brands, formats, claims, pack sizes, or price points attract attention at the point of purchase. | Improve packaging, shelf messaging, product hierarchy, or retail activation strategy. |
| Claim understanding | Whether consumers understand benefit claims, dosage instructions, usage limits, and safety information correctly. | Simplify packaging copy, refine product claims, improve patient information, or adjust campaign wording. |
| Price sensitivity | How consumers compare branded products, generics, local alternatives, imported products, or pharmacy-recommended substitutes. | Review pricing, pack size, promotion strategy, or value communication. |
| Repeat purchase drivers | Why consumers repurchase, switch brands, stop using the product, or rely on pharmacist advice again. | Improve retention messaging, product experience, loyalty strategy, or post-purchase education. |
11. Medical Device And Diagnostics Usability Research
Medical device and diagnostics usability research evaluates whether target users can operate and interpret a product safely in real-world care settings.
For this category, usability is directly linked to result accuracy and user trust. Research reveals where patients, caregivers, clinicians, or lab teams face friction before those issues affect wider rollout.
For this category, usability is directly linked to result accuracy and user trust. Research reveals where patients, caregivers, clinicians, or lab teams face friction before those issues affect wider rollout.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Handling and setup | How correctly patients, caregivers, or HCPs can prepare and operate the product. | Improve product design, setup guidance, packaging layout, or user instructions. |
| Instruction clarity | How clearly users understand dosage steps, sample collection, result timing, safety warnings, maintenance, or disposal instructions. | Rewrite instructions, add visual guidance, simplify steps, or create training materials. |
| Perceived accuracy and confidence | How strongly users trust the device or monitoring output before acting on it. | Strengthen evidence communication, result explanation, validation messaging, or HCP support content. |
| Workflow fit | How well the device or diagnostic process fits clinical routines, lab processes, pharmacy workflows, or home care routines. | Adjust implementation plan, reduce friction, improve integration, or redesign user flow. |
| Training needs | What users need before they feel confident using the product safely and consistently. | Develop onboarding, HCP training, patient guides, demonstration videos, or support resources. |
| Procurement and adoption barriers | What hospitals, clinics, labs, pharmacies, or distributors need before they approve, purchase, or recommend the product. | Refine procurement messaging, evidence package, training plan, after-sales support, or channel strategy. |
| Post-use experience | What users experience after using the product, including confusion, reassurance, frustration, follow-up needs, or support requests. | Improve post-use communication, customer support, result interpretation, or post-launch monitoring. |
12. Healthcare Market Entry And Local Validation
Healthcare market entry and local validation research assess whether a medicine, medical device, supplement, digital health solution, or care service fits the realities of a new healthcare market.
Healthcare markets are shaped by local access rules and stakeholder power structures. Local validation research reveals whether a product fits the target market’s commercial reality before the team commits major resources.
Healthcare markets are shaped by local access rules and stakeholder power structures. Local validation research reveals whether a product fits the target market’s commercial reality before the team commits major resources.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Local demand | How strongly the product addresses a real need for patients, consumers, HCPs, pharmacists, or healthcare institutions in the target market. | Confirm market potential, refine the target segment, or adjust the entry priority before investment. |
| Competitive benchmarks | Which local, imported, branded, generic, OTC, or alternative products already influence the category. | Refine positioning, identify differentiation gaps, and build competitor-specific messaging. |
| Pricing expectations | Whether the proposed price matches local affordability, perceived value, reimbursement structure, or pharmacy-level purchase behavior. | Adjust pricing logic, value communication, pack size, or launch offer. |
| Channel and distribution fit | How the proposed price fits local affordability, perceived value, reimbursement structure, or pharmacy-level purchase behavior. | Select the right go-to-market channel, validate distributor requirements, or redesign channel strategy. |
| HCP and pharmacist influence | How physicians, specialists, pharmacists, or healthcare advisors shape product awareness, recommendation, and adoption. | Build HCP education, pharmacist engagement, expert validation, or professional communication plans. |
| Partnership risk | How local distributors or commercial representatives perform in credibility and execution capability. | Improve partner selection, define validation criteria, and reduce commercial dependency risk. |
13. Quick-Turn Healthcare Research
Quick-turn healthcare research provides rapid evidence when you face urgent strategic decisions.
You can need fast insight for market entry, message testing, early validation, competitive response, stakeholder feedback, product refinement, or internal decision support. Quick-turn research provides focused findings from relevant healthcare audiences while still protecting respondent screening quality and data reliability.
You can need fast insight for market entry, message testing, early validation, competitive response, stakeholder feedback, product refinement, or internal decision support. Quick-turn research provides focused findings from relevant healthcare audiences while still protecting respondent screening quality and data reliability.
| Research focus | What the study helps validate | Appropriate next step |
|---|---|---|
| Early concept validation | How clearly patients, HCPs, pharmacists, or healthcare consumers understand the idea and see its relevance. | Continue development, refine the concept, or stop weak ideas before major investment. |
| Message testing | Whether healthcare claims, product explanations, patient education materials, or HCP messages are clear and persuasive. | Improve message wording, evidence framing, campaign direction, or medical communication materials. |
| Competitive response | How target audiences react to a competitor launch, pricing change, new product claim, or market movement. | Adjust positioning, update sales materials, or prepare stakeholder-specific response strategies. |
| Product refinement | How well a feature, service model, packaging idea, support program, or digital tool solves a real user problem. | Prioritize product changes, improve user experience, or refine launch scope. |
| Stakeholder feedback | How closely patients, caregivers, HCPs, pharmacists, or payers align with internal assumptions. | Align internal teams around evidence and reduce decision-making based on opinion. |
| Urgent market checks | Which new market, audience, claim, or channel deserves deeper research or immediate commercial action. | Decide whether to proceed, run a larger study, adjust the strategy, or delay launch. |
Discuss your healthcare strategy with TGM Research to define the right use case and build a reliable research plan for your next decision.
